Abstract
Background/Objectives:
Coffee consumption has been hypothesized to be associated with blood pressure (BP), but previous findings are not homogeneous. The aim of this study was to evaluate the association between coffee consumption and the risk of developing hypertension.
Subjects/Methods:
Data on coffee consumption, BP and use of anti-hypertensive medicament were derived from 2725 participants of the Polish arm of the HAPIEE project (Health, Alcohol and Psychosocial factors In Eastern Europe) who were free of hypertension at baseline and followed up for an average of 5 years. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by multivariate logistic regression analyses and stratified for potential confounding factors.
Results:
Coffee consumption was related to decreased age, smoking status and total energy intake. Compared with persons who drink <1 cup coffee per day, systolic BP was significantly associated with coffee consumption and the risk of hypertension was lower for individuals consuming 3–4 cups per day. Despite the analysis stratified by gender showed that the protective effect of coffee consumption on hypertension was significant only in women, the analysis after stratification by smoking status revealed a decreased risk of hypertension in non-smokers drinking 3–4 cups of coffee per day in both sexes (OR 0.41, 95% CI: 0.21, 0.79 for men and OR 0.54, 95% CI: 0.29, 0.99 for women). Upper category coffee consumption (>4 cups per day) was not related to significant increased risk of hypertension.
Conclusions:
Relation between coffee consumption and incidence of hypertension was related to smoking status. Consumption of 3–4 cups of coffee per day decreased the risk of hypertension in non-smoking men and women only.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Association between hypertension and coffee drinking based on CYP1A2 rs762551 single nucleotide polymorphism in Taiwanese
Nutrition & Metabolism Open Access 14 August 2021
-
Coffee and Arterial Hypertension
Current Hypertension Reports Open Access 01 July 2021
-
Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study
European Journal of Nutrition Open Access 25 February 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout


References
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J . Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–223.
Grigg D . The worlds of tea and coffee: patterns of consumption. GeoJournal 2003; 57: 283–294.
Higdon JV, Frei B . Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006; 46: 101–123.
Godos J, Pluchinotta FR, Marventano S, Buscemi S, Li Volti G, Galvano F et al. Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr 2014; 21: 1–12.
Grosso G, Stepaniak U, Topor-Mądry R, Szafraniec K, Pająk A . Estimated dietary intake and major food sources of polyphenols in the Polish arm of the HAPIEE study. Nutrition 2014; 30: 1398–1403.
Umemura T, Ueda K, Nishioka K, Hidaka T, Takemoto H, Nakamura S et al. Effects of acute administration of caffeine on vascular function. Am J Cardiol 2006; 98: 1538–1541.
Caprioli G, Cortese M, Maggi F, Minnetti C, Odello L, Sagratini G et al. Quantification of caffeine, trigonelline and nicotinic acid in espresso coffee: the influence of espresso machines and coffee cultivars. Int J Food Sci Nutr 2014; 65: 465–469.
Grosso G, Marventano S, Galvano F, Pajak A, Mistretta A . Factors associated with metabolic syndrome in a Mediterranean population: role of caffeinated beverages. J Epidemiol 2014; 24: 327–333.
Grosso G, Stepaniak U, Micek A, Topor-Mądry R, Pikhart H, Szafraniec K et al. Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr e-pub ahead of print 4 November 2014.
Geleijnse JM . Habitual coffee consumption and blood pressure: an epidemiological perspective. Vasc Health Risk Manag 2008; 4: 963–970.
Uiterwaal CS, Verschuren WM, Bueno-de-Mesquita HB, Ocke M, Geleijnse JM, Boshuizen HC et al. Coffee intake and incidence of hypertension. Am J Clin Nutr 2007; 85: 718–723.
Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC . Habitual caffeine intake and the risk of hypertension in women. JAMA 2005; 294: 2330–2335.
Palatini P, Dorigatti F, Santonastaso M, Cozzio S, Biasion T, Garavelli G et al. Association between coffee consumption and risk of hypertension. Ann Med 2007; 39: 545–553.
Guessous I, Pruijm M, Ponte B, Ackermann D, Ehret G, Ansermot N et al. Associations of ambulatory blood pressure with urinary caffeine and caffeine metabolite excretions. Hypertension 2015; 65: 691–696.
Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM . Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 2005; 23: 921–928.
Steffen M, Kuhle C, Hensrud D, Erwin PJ, Murad MH . The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens 2012; 30: 2245–2254.
Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E . The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr 2011; 94: 1113–1126.
Guessous I, Eap CB, Bochud M . Blood pressure in relation to coffee and caffeine consumption. Curr Hypertens Rep 2014; 16: 468.
Guessous I, Dobrinas M, Kutalik Z, Pruijm M, Ehret G, Maillard M et al. Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension. Hum Mol Genet 2012; 21: 3283–3292.
Peasey A, Bobak M, Kubinova R, Malyutina S, Pajak A, Tamosiunas A et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health 2006; 6: 255.
Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51–65.
Brunner E, Stallone D, Juneja M, Bingham S, Marmot M . Dietary assessment in Whitehall II: comparison of 7 d diet diary and food-frequency questionnaire and validity against biomarkers. Br J Nutr 2001; 86: 405–414.
Boylan S, Welch A, Pikhart H, Malyutina S, Pajak A, Kubinova R et al. Dietary habits in three Central and Eastern European countries: the HAPIEE study. BMC Public Health 2009; 9: 439.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.
Corti R, Binggeli C, Sudano I, Spieker L, Hanseler E, Ruschitzka F et al. Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking. Circulation 2002; 106: 2935–2940.
Salomone F, Li Volti G, Vitaglione P, Morisco F, Fogliano V, Zappalà A et al. Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease. Transl Res 2013; 163: 593–602.
Ranheim T, Halvorsen B . Coffee consumption and human health—beneficial or detrimental?—Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 2005; 49: 274–284.
Park JB . Isolation and quantification of major chlorogenic acids in three major instant coffee brands and their potential effects on H2O2-induced mitochondrial membrane depolarization and apoptosis in PC-12 cells. Food Funct 2013; 4: 1632–1638.
Zhao Y, Wang J, Ballevre O, Luo H, Zhang W . Antihypertensive effects and mechanisms of chlorogenic acids. Hypertens Res 2012; 35: 370–374.
Kozuma K, Tsuchiya S, Kohori J, Hase T, Tokimitsu I . Antihypertensive effect of green coffee bean extract on mildly hypertensive subjects. Hypertens Res 2005; 28: 711–718.
Watanabe T, Arai Y, Mitsui Y, Kusaura T, Okawa W, Kajihara Y et al. The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin Exp Hypertens 2006; 28: 439–449.
Suzuki A, Fujii A, Yamamoto N, Yamamoto M, Ohminami H, Kameyama A et al. Improvement of hypertension and vascular dysfunction by hydroxyhydroquinone-free coffee in a genetic model of hypertension. FEBS Lett 2006; 580: 2317–2322.
Suzuki A, Yamamoto N, Jokura H, Yamamoto M, Fujii A, Tokimitsu I et al. Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats. J Hypertens 2006; 24: 1065–1073.
Li PG, Xu JW, Ikeda K, Kobayakawa A, Kayano Y, Mitani T et al. Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats. Hypertens Res 2005; 28: 369–377.
Actis-Goretta L, Ottaviani JI, Fraga CG . Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem 2006; 54: 229–234.
Ardiansyah, Ohsaki Y, Shirakawa H, Koseki T, Komai M . Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneously hypertensive rats. J Agric Food Chem 2008; 56: 2825–2830.
Suzuki A, Kagawa D, Fujii A, Ochiai R, Tokimitsu I, Saito I . Short- and long-term effects of ferulic acid on blood pressure in spontaneously hypertensive rats. Am J Hypertens 2002; 15: 351–357.
Suzuki A, Kagawa D, Ochiai R, Tokimitsu I, Saito I . Green coffee bean extract and its metabolites have a hypotensive effect in spontaneously hypertensive rats. Hypertens Res 2002; 25: 99–107.
Suzuki A, Yamamoto M, Jokura H, Fujii A, Tokimitsu I, Hase T et al. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens 2007; 20: 508–513.
Buscemi S, Verga S, Batsis JA, Tranchina MR, Belmonte S, Mattina A et al. Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects. Eur J Clin Nutr 2009; 63: 1200–1205.
Buscemi S, Verga S, Batsis JA, Donatelli M, Tranchina MR, Belmonte S et al. Acute effects of coffee on endothelial function in healthy subjects. Eur J Clin Nutr 2010; 64: 483–489.
Buscemi S, Batsis JA, Arcoleo G, Verga S . Coffee and endothelial function: a battle between caffeine and antioxidants? Eur J Clin Nutr 2010; 64: 1242–1243.
Zhang Z, Hu G, Caballero B, Appel L, Chen L . Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. Am J Clin Nutr 2011; 93: 1212–1219.
Shi J, Benowitz NL, Denaro CP, Sheiner LB . Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effects. Clin Pharmacol Ther 1993; 53: 6–14.
Jee SH, He J, Whelton PK, Suh I, Klag MJ . The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 1999; 33: 647–652.
Suzuki A, Fujii A, Jokura H, Tokimitsu I, Hase T, Saito I . Hydroxyhydroquinone interferes with the chlorogenic acid-induced restoration of endothelial function in spontaneously hypertensive rats. Am J Hypertens 2008; 21: 23–27.
Ochiai R, Chikama A, Kataoka K, Tokimitsu I, Maekawa Y, Ohishi M et al. Effects of hydroxyhydroquinone-reduced coffee on vasoreactivity and blood pressure. Hypertens Res 2009; 32: 969–974.
Yamaguchi T, Chikama A, Mori K, Watanabe T, Shioya Y, Katsuragi Y et al. Hydroxyhydroquinone-free coffee: a double-blind, randomized controlled dose-response study of blood pressure. Nutr Metab Cardiovasc Dis 2008; 18: 408–414.
Halliwell B, Long LH, Yee TP, Lim S, Kelly R . Establishing biomarkers of oxidative stress: the measurement of hydrogen peroxide in human urine. Curr Med Chem 2004; 11: 1085–1092.
Acknowledgements
The study has been funded by the Wellcome Trust (grants 064947/Z/01/Z and 081081/Z/06/Z), US National Institute on Ageing (grant 1R01 AG23522-01) and the MacArthur Foundation Initiative on Social Upheaval and Health (award 71208).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website
Supplementary information
Rights and permissions
About this article
Cite this article
Grosso, G., Stepaniak, U., Polak, M. et al. Coffee consumption and risk of hypertension in the Polish arm of the HAPIEE cohort study. Eur J Clin Nutr 70, 109–115 (2016). https://doi.org/10.1038/ejcn.2015.119
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2015.119
This article is cited by
-
Association between hypertension and coffee drinking based on CYP1A2 rs762551 single nucleotide polymorphism in Taiwanese
Nutrition & Metabolism (2021)
-
Coffee and Arterial Hypertension
Current Hypertension Reports (2021)
-
Caffeine and caffeine metabolites in relation to hypertension in U.S. adults
European Journal of Clinical Nutrition (2020)
-
Coffee consumption in hemodialysis patients: how many?
European Journal of Clinical Nutrition (2019)
-
Coffee consumption and risk of hypertension: a dose–response meta-analysis of prospective studies
European Journal of Nutrition (2019)